"L'Institut Bergonié est un établissement de santé privé d'intérêt collectif. Il est le centre de lutte contre le cancer de la Nouvelle-Aquitaine"

During the past decade, Institut Bergonie; Hematologie Oncologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Bergonie; Hematologie Oncologie" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Institut Bergonie; Hematologie Oncologie" are "B-cell Lymphoma" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Institut Bergonie; Hematologie Oncologie" in a lesser frequency.

Most popular intervention types in "Institut Bergonie; Hematologie Oncologie" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Obinutuzumab" (2 trials), "Bendamustine" (1 trials), "Bevacizumab" (1 trials), "CHOP" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Bergonie; Hematologie Oncologie" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Institut Bergonie; Hematologie Oncologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Institut Bergonie; Hematologie Oncologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Bergonie; Hematologie Oncologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".